Addus HomeCare Co. (NASDAQ:ADUS) Receives $133.67 Average Price Target from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been given an average rating of “Buy” by the eleven brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $133.67.

ADUS has been the subject of several recent research reports. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 target price on the stock.

Addus HomeCare Trading Up 0.3 %

Shares of NASDAQ ADUS opened at $124.59 on Wednesday. The company has a 50 day simple moving average of $125.12 and a two-hundred day simple moving average of $125.83. The stock has a market cap of $2.26 billion, a price-to-earnings ratio of 28.51, a PEG ratio of 2.11 and a beta of 1.00. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.03 earnings per share. Analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock valued at $4,930,750. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Quarry LP acquired a new stake in Addus HomeCare during the third quarter worth about $28,000. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $31,000. Farther Finance Advisors LLC raised its position in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares during the period. Sandia Investment Management LP acquired a new position in Addus HomeCare in the second quarter valued at approximately $58,000. Finally, GAMMA Investing LLC grew its position in Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after acquiring an additional 191 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.